Company Overview

ViewRay® Inc., (NASDAQ:VRAY), designs, manufactures and markets MRIdian® the world’s first MRI-guided radiation therapy system that can image and treat cancer patients simultaneously. MRIdian addresses key limitations of existing external-beam radiation therapy technologies because it integrates MRI technology, radiation delivery, and proprietary software to locate, target, and track the position and shape of soft-tissue tumors while radiation is delivered. Real-time MRI-imaging clearly defines the targeted tumor from the surrounding soft tissue and other critical organs during radiation treatment allowing the system to deliver radiation to the tumor accurately while delivering less radiation to healthy tissue. MRIdian’s targeting accuracy combined with improved tumor visibility and accurate dose recording means clinicians can treat patients who may not previously have been considered radiation therapy candidates. ViewRay believes MRIdian may improve the safety and efficacy of radiation therapy, potentially leading to improved patient outcomes with reduced side-effects from off-target radiation delivery.

Financial News

Date Title and Summary Additional Formats
Toggle Summary ViewRay® to Partcipate in the Cantor Global Healthcare Conference
CLEVELAND , Sept. 16, 2021 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will participate in the Cantor Global Healthcare Conference . Scott Drake , President and Chief Executive Officer, and Zach Stassen , Chief Financial Officer, will participate in a fireside chat
Toggle Summary ViewRay® to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
CLEVELAND , Aug. 27, 2021 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that the Company will present at the Morgan Stanley 19 th Annual Global Healthcare Conference. Scott Drake , President and Chief Executive Officer, and Zach Stassen , Chief Financial Officer, will participate in
Toggle Summary Amsterdam University Medical Centers establishes same-day ablative treatment service using MRIdian® to Streamline the Patient Experience.
Innovative program offering patients consult-to-complete treatment in a single visit. CLEVELAND , Aug. 24, 2021 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that the clinical team at Amsterdam University Medical Centers (Amsterdam UMC) has started offering "same-day ablative
Toggle Summary UCLA Health Treats its 1,000th Patient Using MRIdian® MRI-Guided Radiation Therapy
Center Becomes First MRIdian Program in Western U.S. to Reach this Treatment Milestone CLEVELAND , Aug. 17, 2021 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that UCLA Health joins the Siteman Cancer Center at Washington University , Seoul National University Hospital and Amsterdam

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Financial Events

E-mail Alerts

Alerts are e-mailed to you whenever certain new company information is posted to this site. Sign-up Now!
Click here for E-mail Alerts

Transfer Agent
American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
(800) 937-5449
Website: www.amstock.com
Email: info@amstock.com

In Need of Customer Support? Contact

  Language Select